Editorial 240 |
As scientific and research evidence mounts across a multitude of disciplines, it is increasingly becoming clearer that certain fundamental tenets / paradigms underlying treatment approaches to a variety of health conditions are flawed. Periodically, individual cases such as Charlie Gard who suffered from mitochondrial disease and died following withdrawal of his life-support systems explode into the public domain. As recently noted by Martin Walker commenting about the article Mitochondrial “Collateral Damage” Thanks to Big Pharma | Global Research by Dr Gary G. Kohls “Here is another article, to go with the one below about mitochondrial disease. This one is particularly interesting because it mentions the idea that 'inherited' mitochondrial disease has been most frequently alluded to by pharmaceutical corporations and their researchers, when, the author suggests only 10/15% of cases come under this heading while the rest 80/90% of cases have an environmental trigger. Dr Kohls states in the above article Mitochondrial “Collateral Damage” Thanks to Big Pharma | Global Research by Dr Gary G. Kohls “Several years ago I attended a conference that was sponsored by the United Mitochondrial Disease Foundation (UMDF), an organization which seems to be a combination patient advocacy group and a funding organization for mitochondrial researchers. The conference centered entirely upon the rare congenital/inherited forms of mitochondrial disorders that are first diagnosed in infancy and which comprise about 10 – 15 % of cases of known mitochondrial disorders. Included in the long list of disorders are Diabetes, Cancer, Alzheimer disease, Parkinson's disease, cardiovascular disease, Fatigue, including chronic fatigue syndrome, fibromyalgia, and myofascial pain. The flawed paradigms of genetic mutation currently undertaken with regard to cancer has been discussed, particularly in the review of Tripping Over the Truth: The Return of the Metabolic Theory of Cancer by Travis Christofferson. Here are brief introductions to two new titles, which I’m currently reading and intend to review in Positive Health PH Online. In the Foreword by Kelly Turner PhD in The Metabolic Approach to Cancer “…If modern medicine has learned anything about cancer in the last fifty years, it’s that cancer is not a simple disease. In fact, it’s not even a single disease but rather a collection of over one hundred difference diseases – each with mitochondrial dysfunction at its center… In the Foreword by Thomas N. Seyfried PhD in Keto for Cancer “…The cancer field is now stagnating under the weight of traditional therapies (radiation and chemotherapy) that result in unacceptable toxicity and impairment in quality of life, often with little improvement in survival. Even the new immunotherapy drugs are proving to be unacceptably toxic, marginally effective, and inordinately expensive… Recent published research - Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children by Mawson et al.[1] “…compared 261 unvaccinated children with 405 partially or fully vaccinated children, and assessed their overall health based on their mothers' reports of vaccinations and physician-diagnosed illnesses. What it found about increases in immune-mediated diseases like allergies and neurodevelopmental diseases including autism…” is illustrated in the following graphic: Click the image below to connect and play it as a video. www.facebook.com/CMSRI.ChildrensMedicalSafetyResearchInstitute/videos/1600255030004296/ Source: Children's Medical Safety Research Institute I heartily recommend Positive Health PH Online Issue 240 for your reading and education in many fields including CFS-ME, Infrared Saunas, Screen Influence on Sleep Patterns, Parasites, Toxicity, Integrated Medicine, Breakfast, Bodywork, Massage and Activity / Exercise. References
1. Anthony R Mawson Brian D Ray, Azad R Bhuiyan and Binu Jacob. Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children. J Transl Sci. doi: 10.15761/JTS.1000186. 2017. |